SS&C Technologies
SSNC
$82.96
-7.35%
SS&C Technologies is a financial-services software and software-enabled services provider, selling portfolio accounting, fund administration, trading, banking/lending, and wealth-management platforms to asset managers, banks, insurers, and healthcare payers, with roughly 28,800 employees and a business built substantially through acquisition (GlobeOp, Intralinks, DST Systems, Blue Prism). Its identity is that of a mission-critical infrastructure vendor rather than a high-growth disruptor: a sticky, recurring-revenue compounder whose scale in fund administration and transfer agency makes it deeply embedded in clients' back-office workflows, while its software-enabled services segment (roughly $1.41 billion of the latest quarterly revenue) dwarfs its license and professional-services lines. The current investor debate centers on whether SS&C can sustain the reacceleration visible in its fiscal 2026 results — Q2 revenue grew 10.3% year over year to $1.70 billion with net income of $234.8 million — while digesting a debt-funded M&A model that carries roughly 1.1x debt-to-equity and meaningful interest expense. Sentiment has swung positive over the past three months as the shares rallied more than 20% off their summer lows, but the stock remains roughly flat over twelve months and down about 2% year to date, leaving investors to weigh improving organic growth and margin expansion against a valuation that has re-rated sharply from its 2025 trough multiples.…
SSNC
SS&C Technologies
$82.96
Investment Opinion: Should I buy SSNC Today?
Rating: Hold. The core thesis is that SS&C is a sticky, cash-generative infrastructure compounder whose 8.3% free cash flow yield and 10.34% revenue growth justify ownership, but the 20.86% three-month rally has already priced in much of the recovery, leaving only +11.3% upside to the $93.56 average analyst target. The consensus buy rating (mean 1.8) and the $112.00 high target are constructive, but the $82.00 low target sitting at the current price signals that the risk/reward is now balanced rather than compelling.
Supporting evidence: the forward PE of 10.88x against a trailing PE of 26.82x implies the market expects earnings to roughly double, and if the $10.45 consensus EPS materializes, the stock is cheap. Revenue grew 10.34% YoY to $1.696 billion, net margin expanded to 13.85% from 11.76%, EBITDA margin reached 34.66%, and TTM free cash flow of $1.763 billion funds $437.7 million of quarterly buybacks plus $64.0 million of dividends. EV/EBITDA of 12.08x is modest for a 34.7%-margin software business, and the 3.40x PS ratio is well below the 8.77x historical reading, though that discrepancy likely reflects differing share-count bases.
Risks and conditions: the biggest threats are (1) the forward EPS estimate proving to be adjusted rather than GAAP, which would collapse the 10.88x forward PE narrative; (2) a de-rating toward the 15.8-18.0x trailing PE band seen earlier in 2026, implying 30-40% downside; and (3) $107 million quarterly interest expense constraining EPS growth. This Hold would upgrade to Buy if the stock pulls back toward the $77-78 support area (implying ~15x forward PE) or if Q3 results confirm GAAP EPS tracking toward $10.45. It would downgrade to Sell if revenue growth decelerates below 8% or if gross margin falls below 47%. Valuation verdict: fairly valued relative to history and the value end of the software sector — not overvalued, but no longer the deep-value proposition it was at the $61.40 low.
Sign up to view all
SSNC 12-Month Price Forecast
SSNC presents a balanced risk/reward after its 20.86% three-month rally: the operating momentum is real (10.34% revenue growth, 209 basis points of net margin expansion, 34.66% EBITDA margin), but the valuation has already re-rated from 15.83x trailing PE in Q2 2026 to 26.82x today. The forward PE of 10.88x is the pivotal variable — if the $10.45 consensus EPS is validated as GAAP, the stock is deeply undervalued; if it is adjusted, the stock is fairly to richly valued. The 8.3% free cash flow yield and $437.7 million quarterly buyback provide a valuation floor, while the 1.11x debt-to-equity and $107 million quarterly interest expense cap upside. I would upgrade to bullish if Q3 results confirm GAAP EPS tracking toward $10.45 or if the stock pulls back toward $77-78 support, and downgrade to bearish if revenue growth falls below 8% or gross margin drops below 47%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on SS&C Technologies's 12-month outlook, with a consensus price target around $96.11 and implied upside of +15.8% versus the current price.
Average Target
$96.11
0 analysts
Implied Upside
+15.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$82 - $110
Analyst target range
Coverage is solid for a large-cap software name, with 9 analysts publishing targets and a consensus recommendation of "buy" (mean rating of 1.8 on a 1-to-5 scale where 1 is strong buy). The average target price of $93.56 implies roughly +11.3% upside from the current $84.07, a moderate rather than aggressive bullish stance that is consistent with a stock that has already rallied 20.9% in three months. The consensus leans constructive but not euphoric — the average target sits only about 4% above the 52-week high of $89.93, suggesting analysts see limited room for multiple expansion beyond a reclaim of the prior peak. Institutional ratings activity supports the positive tilt: RBC Capital reiterated Outperform on August 31, 2026, DA Davidson and Needham reiterated Buy in late July, and Jefferies reiterated Buy on July 20, while JP Morgan and Morgan Stanley remain Neutral/Equal Weight — a split that explains the moderate consensus rather than a unanimous strong buy. The target range of $82.00 to $112.00 is wide — a 36.6% spread from low to high — which signals genuine disagreement about the earnings trajectory rather than uniform conviction. The $112.00 high target implies roughly 33% upside and would require the forward EPS estimate of $10.45 to be achieved alongside multiple expansion toward the mid-teens on forward earnings, effectively pricing in successful integration of acquisitions, sustained double-digit organic growth, and further margin expansion. The $82.00 low target sits essentially at the current price and implies the market is already fully valuing the business — it likely assumes margin compression from interest costs, slower organic growth, or a de-rating back toward the 15-18x trailing PE band seen earlier in 2026. With estimated revenue averaging $8.34 billion (range $8.14-8.43 billion) and estimated EPS tightly clustered between $10.13 and $10.60, the dispersion in price targets stems more from multiple assumptions than from fundamental disagreement — a constructive setup, but one where the stock's recent 20.9% run means the risk/reward to consensus is now thinner than it was in July.
Bulls vs Bears: SSNC Investment Factors
The bull case currently has stronger evidence: revenue growth accelerated to 10.34% YoY, net margin expanded 209 basis points to 13.85%, and an 8.3% free cash flow yield underpins aggressive buybacks and dividends. However, the bear case is not weak — the trailing PE of 26.82x is well above the 15.8-18.0x readings earlier in 2026, and the stock's 20.86% three-month rally has already captured much of the recovery. The single most important tension is whether the forward EPS estimate of $10.45 is validated: if it is, the 10.88x forward PE is deeply undervalued; if it proves to be adjusted rather than GAAP earnings, the stock is fairly to richly valued at 26.8x trailing. Resolution of this earnings-quality question, likely at the next quarterly report, will determine whether the rally extends toward the $112 high target or stalls near the $89.93 52-week high.
Bullish
- Revenue reaccelerating to 10.3% YoY: Q2 2026 revenue of $1.696 billion grew 10.34% year over year versus $1.537 billion in Q2 2025, and rose sequentially from $1.647 billion in Q1 2026. This marks a clear acceleration from the mid-single-digit growth implied by the trailing four-quarter base of roughly $6.56 billion, suggesting the acquisition-and-integrate model is yielding organic momentum.
- Free cash flow yield of ~8.3%: TTM free cash flow of $1.763 billion against a $21.36 billion market cap implies an 8.3% FCF yield, with Q2 2026 FCF of $403.4 million on operating cash flow of $416.7 million and capex of just $13.3 million. This cash generation comfortably funds $437.7 million of quarterly buybacks and $64.0 million of dividends while still allowing debt repayment.
- Margin expansion and 34.7% EBITDA margin: Q2 2026 net margin rose to 13.85% from 11.76% a year earlier, operating margin expanded to 24.00% from 22.42%, and EBITDA of $587.7 million represented a 34.66% EBITDA margin. The multi-quarter trajectory from Q4 2025 gross margin of 47.77% to 48.26% in Q2 2026 confirms cost discipline is translating into profitability.
- Forward PE of 10.88x signals deep value: The trailing PE of 26.82x collapses to a forward PE of just 10.88x based on the consensus EPS estimate of $10.45, implying the market expects earnings to roughly double. Even if the forward figure reflects adjusted rather than GAAP EPS, the gap is wide enough to offer a margin of safety at 12.08x EV/EBITDA for a business with 34.7% EBITDA margins.
Bearish
- Valuation has already re-rated sharply: The trailing PE of 26.82x sits well above the 15.83x recorded in Q2 2026 and 17.97x in Q1 2026, while the 3.10x PB is near the top of its recent 2.24x-3.13x band. The stock has rallied 20.86% in three months, meaning the easy mean-reversion trade off the $61.40 low is gone and further upside requires earnings validation rather than multiple expansion.
- Leverage and $107 million quarterly interest drag: Debt-to-equity of 1.11x and debt-to-capitalization near 53.9% carry interest expense of $107.0 million per quarter, limiting interest coverage to roughly 3.8x. This debt-funded M&A model constrains flexibility and makes EPS sensitive to rate moves, a risk amplified by the current ratio of just 1.07.
- Services-heavy mix caps the multiple: Software-enabled services contributed $1.408 billion of the $1.696 billion quarterly revenue, with maintenance and term licenses at $256.2 million and perpetual licenses a negligible $4.4 million. This outsourcing-heavy mix supports durability but structurally limits the SaaS-style multiple the market is willing to pay, explaining the 3.40x PS ratio versus pure-play software peers.
- Relative performance still lags over 12 months: Despite the 20.86% three-month rally, the stock is up only 5.70% over twelve months versus SPY's 15.53%, producing a relative strength of -9.83 points for the year and -13.89 points YTD. The failure to reclaim the $89.93 52-week high despite the powerful run suggests overhead supply and incomplete trend reversal.
SSNC Technical Analysis
SSNC is in a recovery uptrend rather than a sustained secular advance: the stock is up 5.70% over the past year but has rallied 20.86% over three months and 16.59% over six months, a profile consistent with a base-and-breakout rather than a steady climb. At $84.07, the shares sit at roughly 79% of the 52-week range bounded by a $61.40 low and an $89.93 high — closer to the top of the band than the middle, which signals that momentum buyers are in control but also that the easy mean-reversion trade off the lows has already been captured. The year-to-date change of -1.96% versus a 52-week gain of 5.70% confirms the stock spent the first half of the year under pressure before turning higher. Recent momentum is clearly accelerating: the 1-month gain of 4.37% stacks on top of the 20.86% three-month move, and the 1-month relative strength versus SPY of +3.15 points (against a 1-year relative strength of -9.83) shows the stock flipping from laggard to leader. The 3-month relative strength of +18.17 points is the most striking data point — SSNC has outperformed the S&P 500 by more than 18 percentage points since mid-July, a sharp reversal from the -13.89 point YTD relative underperformance. This divergence between weak trailing-year relative performance and strong recent relative performance is characteristic of a trend reversal in progress, though the stock's failure to reclaim its 52-week high despite the powerful three-month run suggests some supply overhead. Key levels are well defined: support sits at the $61.40 52-week low, with intermediate support around the $77-78 area that contained the September pullback, while resistance is the $89.93 52-week high — a breakout above that level would confirm the reversal and likely trigger momentum-fund accumulation, whereas a breakdown below $77 would signal the summer rally was a failed breakout. With a beta of 1.089, SSNC is only about 9% more volatile than the market, so position sizing need not be dramatically discounted, but the 31.12% maximum drawdown over the period is a reminder that this name can inflict meaningful pain during risk-off episodes; the short ratio of 2.87 days-to-cover is modest and offers little squeeze fuel.
Beta
1.09
1.09x market volatility
Max Drawdown
-30.8%
Largest decline past year
52-Week Range
$61-$90
Price range past year
Annual Return
+2.6%
Cumulative gain past year
| Period | SSNC Return | S&P 500 |
|---|---|---|
| 1m | +4.1% | -1.0% |
| 3m | +12.3% | +2.9% |
| 6m | +23.3% | +6.5% |
| 1y | +2.6% | +13.1% |
| ytd | -3.3% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SSNC Fundamental Analysis
Revenue is reaccelerating on a sequential and annual basis: Q2 2026 revenue of $1.696 billion grew 10.34% year over year versus $1.537 billion in Q2 2025, and rose sequentially from $1.647 billion in Q1 2026 and $1.654 billion in Q4 2025. The trailing four-quarter revenue base of roughly $6.56 billion reflects steady mid-to-high single-digit growth, and the segment mix explains the durability — software-enabled services contributed $1.408 billion of the latest quarter, with maintenance and term licenses at $256.2 million, professional services at $26.9 million, and perpetual licenses a negligible $4.4 million. The growth trend implies a business that is compounding through recurring outsourcing and administration contracts rather than cyclical license sales, which supports the investment case for defensive, cash-generative compounding, though the heavy services mix also caps the multiple the market is willing to pay relative to pure-play SaaS. Profitability is solid and improving: Q2 2026 net income was $234.8 million on a 13.85% net margin, up from $180.8 million and an 11.76% margin in Q2 2025, while gross margin held at 48.26% (versus 47.95% a year earlier) and operating margin expanded to 24.00% from 22.42%. The multi-quarter trajectory is constructive — gross margin has moved from 47.77% in Q4 2025 to 48.68% in Q1 2026 to 48.26% in Q2 2026, and operating margin from 22.29% to 24.79% to 24.00% — with EBITDA of $587.7 million representing a 34.66% EBITDA margin. Interest expense of $107.0 million remains a meaningful drag (interest coverage of roughly 3.8x), but the direction of travel on margins is favorable and consistent with management's cost-discipline narrative. The balance sheet is leveraged but manageable: debt-to-equity of 1.11x, a current ratio of 1.07, and cash of $3.42 billion at Q2 2026 against total debt-to-capitalization near 53.9%. Free cash flow is the standout — $1.763 billion TTM, with Q2 2026 FCF of $403.4 million on operating cash flow of $416.7 million and capex of just $13.3 million, implying a free-cash-flow yield of roughly 8.3% on the $21.36 billion market cap. ROE of 11.57% and ROA of 4.89% are modest for a software business but reflect the acquired-goodwill-heavy asset base; the company is clearly self-funding, returning capital via $437.7 million of buybacks and $64.0 million of dividends in Q2 alone while still repaying debt, which argues the leverage is not a solvency risk but a capital-allocation choice.
Quarterly Revenue
$1.7B
2026-06
Revenue YoY Growth
+10.3%
YoY Comparison
Gross Margin
48.3%
Latest Quarter
Free Cash Flow
$1.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SSNC Overvalued?
Because SSNC is profitable — Q2 2026 net income of $234.8 million and TTM EPS positive — the PE ratio is the appropriate primary metric, and the trailing PE of 26.82x against a forward PE of just 10.88x is the single most important valuation signal in this dataset. That gap implies the market expects earnings to roughly double, consistent with the analyst consensus EPS estimate of $10.45 for the forward period versus the current reported quarterly EPS run-rate, though investors should treat the forward figure with caution given the wide divergence from trailing GAAP earnings and the possibility that it reflects adjusted rather than GAAP EPS. On the secondary metrics, the stock trades at 3.40x sales, 3.10x book, 12.08x EV/EBITDA, and 12.24x price-to-cash-flow, with a PEG of 4.87 that looks expensive on trailing growth but far more reasonable if forward earnings materialize. Peer comparison is constrained by the absence of a supplied industry-average multiple, but the internal evidence is telling: EV/EBITDA of 12.08x is modest for a software company with 34.7% EBITDA margins, while the 3.40x PS ratio is well below the 8.77x PS recorded in the Q2 2026 historical ratios table — a discrepancy that likely reflects differing share-count or market-cap bases in the historical data and should be treated as directional rather than precise. Relative to the broader application-software sector, SSNC's 26.8x trailing PE and 12.1x EV/EBITDA sit at the value end of the spectrum, which is defensible given its lower organic growth, acquisition-driven model, and leverage, but leaves room for re-rating if organic growth holds above 10%. Historical context is the most compelling part of the valuation case: the stock's own PE history shows 15.83x in Q2 2026, 17.97x in Q1 2026, 27.32x in Q4 2025, and 25.80x in Q3 2025, while PS has ranged from 8.77x to 13.86x over the same span and PB from 2.24x to 3.13x. The current 3.10x PB sits near the top of that band and the 26.82x trailing PE is above the recent 15.8-18.0x readings, suggesting the market has already priced in a meaningful recovery — the stock is no longer the deep-value proposition it was earlier in 2026, and further upside likely requires the forward earnings estimate to be validated rather than multiple expansion alone.
PE
26.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 16x~34x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the debt-funded acquisition model. Debt-to-equity of 1.11x and debt-to-capitalization near 53.9% generate $107.0 million of quarterly interest expense, capping interest coverage at roughly 3.8x and making EPS sensitive to refinancing costs. The current ratio of 1.07 leaves little liquidity cushion, and the services-heavy revenue mix — $1.408 billion of $1.696 billion from software-enabled services — creates concentration in fund administration and transfer agency, where client losses or fee compression would hit the largest segment directly. Integration risk from GlobeOp, Intralinks, DST Systems, and Blue Prism remains a persistent operational overhang, and the modest 11.57% ROE reflects an acquired-goodwill-heavy asset base that could require impairment if acquisitions underperform.
Market and competitive risks stem from valuation compression and sector rotation. At 26.82x trailing PE and 3.40x PS, SSNC trades at a premium to its own recent 15.8-18.0x PE history, so any disappointment in the forward EPS estimate of $10.45 could trigger a de-rating toward that band, implying roughly 30-40% downside on the multiple alone. The beta of 1.089 means the stock is only ~9% more volatile than the market, but the 31.12% maximum drawdown over the period shows it can inflict meaningful pain during risk-off episodes. Competition from pure-play SaaS and fund-administration rivals, plus regulatory scrutiny of financial-services outsourcing, could pressure pricing; the absence of recent news leaves the competitive landscape opaque, but the services-heavy model is structurally exposed to fee compression as asset managers consolidate.
Worst-case scenario: a forward EPS miss (revealing the $10.45 estimate as adjusted rather than GAAP), combined with a de-rating to the 15.8x trailing PE seen in Q2 2026, would compress the multiple by roughly 40%. Layered on top of margin pressure from $107 million quarterly interest expense and slower organic growth, the stock could retest its 52-week low of $61.40, representing a -27% decline from $84.07. A more severe outcome — a credit-rating downgrade or a large dilutive acquisition — could push shares toward the $55-60 range, a -29% to -35% loss. The $82.00 analyst low target offers a milder downside of -2.5%, but the 31.12% historical max drawdown is the more realistic stress benchmark for a leveraged, acquisition-driven name.
FAQ
Ranked by severity: (1) Valuation de-rating risk — the 26.82x trailing PE is well above the 15.8-18.0x band seen earlier in 2026, and a reversion could imply 30-40% downside toward the $61.40 52-week low. (2) Earnings-quality risk — the 10.88x forward PE depends on the $10.45 EPS estimate, which may reflect adjusted rather than GAAP earnings given the wide gap from trailing GAAP. (3) Financial leverage risk — debt-to-equity of 1.11x and $107 million quarterly interest expense cap EPS growth and make the stock sensitive to refinancing costs, with a current ratio of just 1.07. (4) Concentration risk — software-enabled services at $1.408 billion of $1.696 billion quarterly revenue exposes the company to fee compression in fund administration and transfer agency as asset managers consolidate.
The 12-month forecast has three scenarios: a 25% probability bull case targeting $100-112 (validating the $10.45 forward EPS and breaking through the $89.93 52-week high toward the $112 analyst high), a 50% probability base case targeting $88-96 (consolidation around the 52-week high as the market awaits earnings confirmation, approaching the $93.56 average target), and a 25% probability bear case targeting $61-78 (a de-rating toward the 15.8x trailing PE band or a forward EPS miss, retesting the $77-78 support and potentially the $61.40 low). The base case is most likely, with the key assumption being that revenue growth moderates to 8-10% and margins hold near 13-14% net and 34-35% EBITDA.
SSNC is fairly valued on trailing metrics and potentially undervalued on forward metrics. The trailing PE of 26.82x is above the 15.83x recorded in Q2 2026 and 17.97x in Q1 2026, and the 3.10x PB is near the top of its 2.24x-3.13x recent band, suggesting the market has already priced in a recovery. However, the forward PE of 10.88x based on the $10.45 consensus EPS implies the market expects earnings to roughly double, and EV/EBITDA of 12.08x is modest for a 34.7%-margin software business. The market is paying a fair price that embeds an optimistic earnings assumption — if the forward EPS is validated, the stock is undervalued; if it is adjusted rather than GAAP, the stock is overvalued at 26.8x trailing.
From a risk/reward perspective, SSNC is a reasonable but not compelling buy at $84.07. The average analyst target of $93.56 implies +11.3% upside, and the $112.00 high target offers 33%, but the $82.00 low target sits essentially at the current price, signaling limited margin of safety after the 20.86% three-month rally. The biggest downside risk is a de-rating toward the 15.8-18.0x trailing PE band seen in Q2 2026, which could take the stock toward the $61.40 52-week low (-27%). The stock is a good buy for value-oriented investors with a 12-18 month horizon who believe the $10.45 forward EPS estimate is achievable, and a poor buy for momentum traders chasing the recent rally without a catalyst.
SSNC is better suited for long-term holding than short-term trading. The business is a sticky, recurring-revenue compounder with an 8.3% free cash flow yield, a 1.19% dividend yield, and a beta of 1.089 that limits volatility relative to high-growth software peers. However, the 31.12% maximum drawdown and the stock's 5.70% one-year return versus SPY's 15.53% show that short-term momentum can reverse sharply, and the 20.86% three-month rally has already captured much of the near-term upside. Earnings visibility is moderate — the forward EPS estimate of $10.45 is tightly clustered ($10.13-$10.60) but its GAAP versus adjusted status is unresolved. A suggested minimum holding period of 12-18 months allows time for the forward earnings thesis to be validated across two to three quarterly reports.